-
<![CDATA[Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD]]>
14 Nov 2025 05:47 GMT
… addressing lung cancer, a predominately asymptomatic cancer until it has metastasized. … Friedberg noted that the most common clinical presentation of lung cancer … to identify potentially deadly lung cancer sooner than anticipated.
“Typically …
-
<![CDATA[Intracranial activity of ifinatamab deruxtecan (I-DXd) in patients with extensive-stage small cell lung cancer and baseline brain metastases: Primary analysis of IDeate-Lung01]]>
12 Nov 2025 17:21 GMT
… small cell lung cancer (ES-SCLC), including those with baseline brain metastases.
Dr …
-
Non-Small Cell Lung Cancer Therapeutics Market to Reach US$ 64.92 Billion by 2033 | Datam Intelligence
12 Nov 2025 13:38 GMT
… patients with locally advanced or metastatic EGFR‑mutated NSCLC who have … patients with locally advanced or metastatic NSCLC harbouring EGFR exon 20 … :
Squamous Non-Small Cell Lung Cancer Therapeutics Market
lung cancer therapeutics market 2025
Kailas …
-
Pharmac To Fund Five Medicines For Multiple Sclerosis, Breast Cancer, Eye Conditions, And Lung Cancer
12 Nov 2025 01:12 GMT
… breast cancer, eye conditions, and lung cancer will benefit from five medicines … ) infusion medicines for HER2-positive metastatic breast cancer.
Faricimab (Vabysmo) – … ROS1-positive non-small cell lung cancer.
Bevacizumab (Avastin) – secured ongoing access …
-
Rearrangement of 3D genome organization in breast cancer epithelial to mesenchymal transition and metastasis organotropism
12 Nov 2025 22:51 GMT
… events widely known as metastasis organotropism. This phenomenon, … triple-negative subtypes, metastatic cells exhibit higher percentages … genome organization data of metastatic progression, which is … spectrum of breast and lung cancer and normal cell lines. …
-
EGFR lung cancer care shifts to combo therapies, but reimbursement gaps limit access in Korea
11 Nov 2025 08:04 GMT
… treatment of EGFR-mutated metastatic NSCLC in the U … “Treatment for EGFR-mutated lung cancer is evolving beyond monotherapy. … chemotherapy for EGFR-mutated lung cancer. This improved patient access … with locally advanced or metastatic NSCLC with an EGFR …
-
The Intricate Web of MicroRNAs in Modulating EGFR-TKI Resistance in Non-Small Cell Lung Cancer: A Comprehensive Review
11 Nov 2025 07:13 GMT
… osimertinib resistance in lung cancer by inhibiting the … or metastatic EGFR mutation-positive non-small-cell lung cancer ( … sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways … non-small cell lung cancer. Transl Lung Cancer Res. 2022;11 …
-
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
11 Nov 2025 07:00 GMT
… of extensive stage small cell lung cancer (ES-SCLC) and Merkle Cell … where the disease has already metastasized, resulting in a poor prognosis … for extensive stage small cell lung cancer (ES-SCLC) and Merkel Cell …
-
<![CDATA[A Story of Staying Active After a Lung Cancer Diagnosis]]>
11 Nov 2025 05:19 GMT
… around who can develop lung cancer.
Despite ongoing treatment … about his story during Lung Cancer Awareness Month, observed annually … ultimately lead to your lung cancer diagnosis?
Nitsche: Actually, … they found lung cancer; the cancer had metastasized to my …
-
Booking Health Announces Expanded Access to Stage 4 Lung Cancer Treatments During Lung Cancer Awareness Month
10 Nov 2025 15:27 GMT
… only available systemic treatment for metastatic lung cancer. This approach uses cytotoxic … to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, … valuable for small, well-defined lung tumors or oligometastatic disease. This …